Literature DB >> 15990629

Celiac disease: from inflammation to atrophy: a long-term follow-up study.

Marja-Leena Lähdeaho1, Katri Kaukinen, Pekka Collin, Tarja Ruuska, Jukka Partanen, Anna-Maija Haapala, Markku Mäki.   

Abstract

OBJECTIVES: Celiac disease develops gradually from lymphocytosis, crypt hyperplasia and minor villous atrophy to overt villous atrophy. It IS NOT known how such minor mucosal changes predict eventual celiac disease. The aim of this study was to evaluate the role of intraepithelial lymphocytosis and marginally decreased villous height/crypt depth ratio in the development of overt villous atrophy in a long-term follow-up.
METHODS: The authors evaluated 980 small bowel biopsies of children who had previously been studied and found to be histologically negative for celiac disease between 1976 and 1992. Villous height/crypt depth ratio and the number of intraepithelial lymphocytes were measured in these initial biopsies. Cases with slight biopsy changes were identified for further study and sex and age matched subjects with normal biopsies from same group were selected as controls. They all were asked to submit serum samples for gliadin, endomysial and tissue transglutaminase antibodies 8 to 28 years after the initial biopsy. Those with positive screening tests were asked to undergo endoscopy and small intestinal biopsy.
RESULTS: 236 cases with slight changes were identified, and 236 with normal mucosa served as controls; 76 cases and 68 controls participated in the follow-up study. Ten individuals had positive screening test results. Two new celiac disease patients, one in each group, were found. Four patients in the case group had been diagnosed with celiac disease by routine procedures during the follow-up. Thus, five cases and one control had developed celiac disease.
CONCLUSIONS: Small bowel mucosal lymphocytosis or slight reduction in villous height/crypt depth ratio are common findings in patients with suspicion of celiac disease. These findings alone are poor predictors of celiac disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990629     DOI: 10.1097/01.mpg.0000161972.60610.0e

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  11 in total

1.  Histologic evidence for mild lesions in coeliac disease: the challenge is open.

Authors:  Paola Ilaria Bianchi; Federico Biagi; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-05-15       Impact factor: 3.397

2.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

3.  Immunohistochemical CD3 staining detects additional patients with celiac disease.

Authors:  Amani Mubarak; Victorien M Wolters; Roderick H J Houwen; Fiebo J W ten Kate
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  A Prospective Study on the Usefulness of Duodenal Bulb Biopsies in Celiac Disease Diagnosis in Children: Urging Caution.

Authors:  Juha Taavela; Alina Popp; Ilma Rita Korponay-Szabo; Adina Ene; Martine Vornanen; Päivi Saavalainen; Marja-Leena Lähdeaho; Tarja Ruuska; Kaija Laurila; Alexandru Parvan; Ioana Anca; Kalle Kurppa; Markku Mäki
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

5.  Celiac disease screening assays for children younger than 3 years of age: the performance of three serological tests.

Authors:  Iva Hojsak; Yael Mozer-Glassberg; Netta Segal Gilboa; Ronit Weinberger; Corina Hartman; Raanan Shamir
Journal:  Dig Dis Sci       Date:  2011-08-17       Impact factor: 3.199

6.  Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis.

Authors:  M Esteve; M Rosinach; F Fernández-Bañares; C Farré; A Salas; M Alsina; P Vilar; A Abad-Lacruz; M Forné; M Mariné; R Santaolalla; J C Espinós; J M Viver
Journal:  Gut       Date:  2006-05-18       Impact factor: 23.059

7.  Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods.

Authors:  S Rashtak; M W Ettore; H A Homburger; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2008-09-15       Impact factor: 8.171

8.  Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study.

Authors:  Ilma R Korponay-Szabó; Katalin Szabados; Jánosné Pusztai; Katalin Uhrin; Eva Ludmány; Eva Nemes; Katri Kaukinen; Anikó Kapitány; Lotta Koskinen; Sándor Sipka; Anikó Imre; Markku Mäki
Journal:  BMJ       Date:  2007-12-06

Review 9.  Diagnosis of Celiac Disease: Taking a Bite Out of the Controversy.

Authors:  Justine M Turner
Journal:  Dig Dis Sci       Date:  2018-06       Impact factor: 3.199

10.  ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation.

Authors:  Kamran Rostami; Michael N Marsh; Matt W Johnson; Hamid Mohaghegh; Calvin Heal; Geoffrey Holmes; Arzu Ensari; David Aldulaimi; Brigitte Bancel; Gabrio Bassotti; Adrian Bateman; Gabriel Becheanu; Anna Bozzola; Antonio Carroccio; Carlo Catassi; Carolina Ciacci; Alexandra Ciobanu; Mihai Danciu; Mohammad H Derakhshan; Luca Elli; Stefano Ferrero; Michelangelo Fiorentino; Marilena Fiorino; Azita Ganji; Kamran Ghaffarzadehgan; James J Going; Sauid Ishaq; Alessandra Mandolesi; Sherly Mathews; Roxana Maxim; Chris J Mulder; Andra Neefjes-Borst; Marie Robert; Ilaria Russo; Mohammad Rostami-Nejad; Angelo Sidoni; Masoud Sotoudeh; Vincenzo Villanacci; Umberto Volta; Mohammad R Zali; Amitabh Srivastava
Journal:  Gut       Date:  2017-09-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.